Abstract
The fifth author’s middle initial is missing. The correct name is: Ashwani K. Singal. The correct citation is: Axley P, Mudumbi S, Sarker S, Kuo Y-F, Singal AK (2018) Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE 13(5): e0197117. https://doi.org/10.1371/journal.pone.0197117.
| Original language | English (US) |
|---|---|
| Article number | e0199402 |
| Journal | PLoS One |
| Volume | 13 |
| Issue number | 8 |
| DOIs |
|
| State | Published - Aug 1 2018 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Agricultural and Biological Sciences(all)
Cite this
Correction : Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117). / Axley, Page; Mudumbi, Sandhya; Sarker, Shabnam; Kuo, Yong Fang; Singal, Ashwani K.
In: PLoS One, Vol. 13, No. 8, e0199402, 01.08.2018.Research output: Contribution to journal › Comment/debate
}
TY - JOUR
T1 - Correction
T2 - Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications (PLoS One (2018) 13:5 (e0197117) DOI: 10.1371/journal.pone.0197117)
AU - Axley, Page
AU - Mudumbi, Sandhya
AU - Sarker, Shabnam
AU - Kuo, Yong Fang
AU - Singal, Ashwani K.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - The fifth author’s middle initial is missing. The correct name is: Ashwani K. Singal. The correct citation is: Axley P, Mudumbi S, Sarker S, Kuo Y-F, Singal AK (2018) Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE 13(5): e0197117. https://doi.org/10.1371/journal.pone.0197117.
AB - The fifth author’s middle initial is missing. The correct name is: Ashwani K. Singal. The correct citation is: Axley P, Mudumbi S, Sarker S, Kuo Y-F, Singal AK (2018) Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications. PLoS ONE 13(5): e0197117. https://doi.org/10.1371/journal.pone.0197117.
UR - http://www.scopus.com/inward/record.url?scp=85051215442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051215442&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0199402
DO - 10.1371/journal.pone.0199402
M3 - Comment/debate
VL - 13
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 8
M1 - e0199402
ER -